Literature DB >> 34546284

The role of immature platelet count and immature platelet fraction in determining the need for transfusion in patients undergoing CABG.

Cihan Yücel1, Serkan Ketenciler2, Hüseyin Gemalmaz2, Nihan Kayalar2.   

Abstract

BACKGROUND: Platelet dysfunction has been shown to play a role in postoperative bleeding, however it is not clear whether immature platelets (IP) can induce appropriate homeostasis to prevent excessive bleeding in patients undergoing coronary artery bypass grafting (CABG). The aim of this study was to evaluate the postoperative change in IP count (IPC), IP fraction (IPF) and mean platelet volume (MPV), and to examine their relationship with postoperative bleeding and blood transfusion.
METHODS: One hundred and forty-nine consecutive patients undergoing elective CABG were included in this prospective study. All CABGs were performed by the same surgical team in a standardised method, utilising the on-pump technique. IPC, MPV and IPF were measured pre-operatively, after the completion of surgery, and at the postoperative first, third and fifth days. The primary outcome measure of this study was whether the need for transfusion was associated with IP, IPF, MPV and platelet count.
RESULTS: There was a significant decrease of 7.77% in IPC on the day of the operation. Pre-operative IPC and IPF were correlated with postoperative drainage (p < 0.001), intraoperative blood transfusion (p < 0.001) and intensive care unit blood transfusion (p < 0.001). Pre-operative haemoglobin levels were significantly correlated with length of hospital stay. However, neither pre-operative IPC nor IPF were associated with length of hospital stay. Postoperative IPC was however associated with the length of hospital and intensive care unit stay (p = 0.008 and p = 0.009, respectively).
CONCLUSIONS: Pre-operative IPC and IPF were significantly correlated with postoperative drainage and blood transfusion frequency. In patients undergoing CABG, these can be seen as serious guiding parameters in the estimation of postoperative bleeding.

Entities:  

Keywords:  bleeding; coronary artery bypass grafting; immature platelet fraction; platelets; transfusion

Mesh:

Year:  2021        PMID: 34546284      PMCID: PMC9364473          DOI: 10.5830/CVJA-2021-041

Source DB:  PubMed          Journal:  Cardiovasc J Afr        ISSN: 1015-9657            Impact factor:   0.802


  19 in total

Review 1.  Immature Platelets: Clinical Relevance and Research Perspectives.

Authors:  Eli I Lev
Journal:  Circulation       Date:  2016-10-04       Impact factor: 29.690

2.  Individual Long-Term Mortality Prediction Following Either Coronary Stenting or Bypass Surgery in Patients With Multivessel and/or Unprotected Left Main Disease: An External Validation of the SYNTAX Score II Model in the 1,480 Patients of the BEST and PRECOMBAT Randomized Controlled Trials.

Authors:  Yohei Sotomi; Rafael Cavalcante; David van Klaveren; Jung-Min Ahn; Cheol Whan Lee; Robbert J de Winter; Joanna J Wykrzykowska; Yoshinobu Onuma; Ewout W Steyerberg; Seung-Jung Park; Patrick W Serruys
Journal:  JACC Cardiovasc Interv       Date:  2016-08-08       Impact factor: 11.195

Review 3.  Immature platelets: a review of the available evidence.

Authors:  Naoufal Benlachgar; Kamal Doghmi; Azlarab Masrar; El Mehdi Mahtat; Hicham Harmouche; Zoubida Tazi Mezalek
Journal:  Thromb Res       Date:  2020-07-03       Impact factor: 3.944

4.  Fifty years of coronary artery bypass grafting.

Authors:  Ludovic Melly; Gianluca Torregrossa; Timothy Lee; Jean-Luc Jansens; John D Puskas
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

5.  Utility of the immature platelet fraction in pediatric immune thrombocytopenia: Differentiating from bone marrow failure and predicting bleeding risk.

Authors:  Alicia McDonnell; Karen L Bride; Derick Lim; Michele Paessler; Char M Witmer; Michele P Lambert
Journal:  Pediatr Blood Cancer       Date:  2017-09-17       Impact factor: 3.167

6.  Impact of Thrombocytopenia on Postoperative Bleeding Incidence in Patients Receiving Aspirin Following Coronary Artery Bypass Grafting.

Authors:  Anne M Rodino; James B Henderson; Kelsey F Dobbins; Deanna T Rubin; Ian B Hollis
Journal:  J Pharm Pract       Date:  2020-10-21

Review 7.  Bypass Grafting Versus Percutaneous Intervention-Which Is Better in Multivessel Coronary Disease: Lessons From SYNTAX and Beyond.

Authors:  Vasim Farooq; Patrick W Serruys
Journal:  Prog Cardiovasc Dis       Date:  2015-10-31       Impact factor: 8.194

8.  Determinants of Value in Coronary Artery Bypass Grafting.

Authors:  Alexander A Brescia; Joceline V Vu; Chang He; Jun Li; Steven D Harrington; Michael P Thompson; Edward C Norton; Scott E Regenbogen; John D Syrjamaki; Richard L Prager; Donald S Likosky
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2020-11-12

9.  Risk factors for in-hospital mortality after coronary artery bypass grafting in patients 80 years old or older: a retrospective case-series study.

Authors:  Jacek Piątek; Anna Kędziora; Janusz Konstanty-Kalandyk; Grzegorz Kiełbasa; Marta Olszewska; Bryan HyoChan Song; Karol Wierzbicki; Irena Milaniak; Tomasz Darocha; Dorota Sobczyk; Bogusław Kapelak
Journal:  PeerJ       Date:  2016-12-01       Impact factor: 2.984

Review 10.  Dual Antiplatelet Therapy before Coronary Artery Bypass Grafting; a Systematic Review and Meta-Analysis.

Authors:  Roxana Sadeghi; Asrin Babahajian; Arash Sarveazad; Naser Kachoueian; Mansour Bahardoust
Journal:  Arch Acad Emerg Med       Date:  2020-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.